Aurelia Healthcare Business Plan › Section 1 › Executive Summary

1.1 The Opportunity

Aurelia Healthcare Group (“AHG”, “Aurelia”, or the “Group”) is a
next-generation private healthcare infrastructure platform designed to
become one of Southern Africa’s leading integrated specialist hospital
operators. The Group will assemble, develop, and operate a portfolio of
premium tertiary and quaternary hospitals, supported by an ecosystem of
outpatient clinics, diagnostic laboratories, dialysis centres, oncology
satellites, and an AI-enabled digital health platform.

South Africa hosts the most sophisticated private healthcare
ecosystem on the African continent, anchored by three publicly-listed
operators — Netcare, Mediclinic Southern Africa, and Life Healthcare —
which together control approximately 83% of private hospital beds and
90% of admissions. Despite this concentration, the Competition
Commission Health Market Inquiry, regulatory bodies, medical scheme
administrators, and policy reformers have identified persistent
structural gaps in tertiary specialist capacity, oncology access,
advanced trauma services, public-private clinical integration, and
middle-market affordability.

Aurelia’s thesis is that a clinically-led, capital-efficient,
technology-forward platform — purpose-built for the post-NHI regulatory
environment and explicitly engineered for development-finance
compatibility — can capture meaningful market share in the most
attractive metropolitan corridors of Johannesburg, Pretoria, Cape Town,
and Durban while generating sustained, risk-adjusted returns for senior
lenders and equity investors.

1.2 Investment Highlights

• Total Funding Sought: USD 240 million from a
  syndicate led by the African Development Bank (AfDB), comprising senior
  project debt, structured equity, sponsor equity, and commercial
  co-financing.
• Projected Equity IRR: 19.4% (base case); range
  11.2% (bear) to 27.5% (bull) across stress-tested scenarios.
• Stabilized EBITDA Margin: 31–35% by Year 6,
  comparable to global premium tertiary benchmarks and meaningfully above
  the South African industry average of approximately 20%.
• Year 10 Exit Enterprise Value: USD 1.8 billion
  (base case); USD 1.45–2.40 billion across exit pathways including JSE
  IPO, strategic trade sale, and DFI secondary.
• DSCR (Debt Service Coverage Ratio): Minimum
  1.45x in stressed scenarios from Year 4 onward; comfortably above lender
  covenant of 1.25x.
• Development Impact: Cumulative ~21,000 direct
  and indirect jobs by Year 10, ~1.5 million annual patient interactions,
  and 240 specialist training slots per annum at full scale.

1.3 Headline Financial Profile

Figure 1.1

1.4 Strategic Differentiators

Tertiary-led portfolio. Aurelia is purpose-built for
tertiary and quaternary acuity from inception, rather than evolving from
a community-hospital base. The flagship Aurelia Medical City in
Johannesburg will offer a Level 1 Trauma Centre, a quaternary cardiac
institute with hybrid OR capability, an integrated oncology institute
(medical, surgical, radiation), advanced renal and transplant services,
a women & children’s hospital, and a teaching & simulation
centre — services that are scarce, high-margin, and structurally
undersupplied in the private South African market.

Digital-native operating model. A single Group
Electronic Medical Record (EMR), AI-augmented diagnostic radiology,
predictive bed-management, and a unified patient portal reduce
length-of-stay, improve clinical decision support, and create
payer-friendly outcome data. Selected reference platforms include Epic
Sky for EMR and aidoc/Rapid AI for radiology — proven in tier-one
international deployments.

Public-private partnership readiness. The Group’s
clinical, governance, and infrastructure architecture is engineered for
accreditation under the National Health Insurance (NHI) Act 20 of 2023,
positioning Aurelia as a credible private-sector contracting partner in
NHI Phase 2 (2026–2028), de-risking against payer-mix concentration and
unlocking volume from the public overflow.

ESG-aligned development model. Aurelia targets 75%
local procurement at scale, 75% renewable energy share, indigent-care
wings within each tertiary site, and binding commitments on women in
clinical leadership and specialist training output — aligning materially
with AfDB’s High 5s, the IFC Performance Standards, and UN SDGs 3, 5, 8,
10 and 17.

Experienced sponsor team. The founding team brings a
combined 120+ years of hospital operations, healthcare investment, and
African infrastructure development experience drawn from the Big-3 South
African operators, leading global hospital groups, and DFI-track-record
sponsors.

1.5 Use of Proceeds — Summary

Figure 1.2

1.6 Transaction Timeline & Path to Financial Close

The Sponsor seeks formal expressions of interest from senior lenders
and equity co-investors within 90 days of distribution, indicative term
sheets within 150 days, and financial close within 270 days.
Construction commencement at the Johannesburg flagship is targeted for
Q3 2026, with first patient admission scheduled for Q3 2028 (Project
Month 34).

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Aurelia Healthcare Holdings (Pty) Ltd.